A drug dismantles a metabolic barrier to anti-tumor immunity

A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a metabolic checkpoint against anti-cancer immune responses. Harnessing that insight, researchers led by Ludwig Lausanne’s Ping-Chih Ho and Yi-Ru Yu — along with Sheue-Fen…

Continue Reading